Latest News & Features
Americas
Kenneth Frazier, the CEO of Merck, is one of three chief executives to step down from US President Donald Trump’s manufacturing council. 15 August 2017
Americas
A US judge has ruled that five patents owned by Pfizer are not invalid as obvious, in a dispute over a generic produced by Mylan. 14 August 2017
Americas
Jazz Pharmaceuticals has taken issue with a trademark application filed by Novartis in the US, filing an opposition at the Trademark Trial and Appeal Board. 14 August 2017
Americas
The US Court of Appeals for the Federal Circuit has rejected a request by Amgen to compel discovery from Hospira over a biosimilar. 11 August 2017
Americas
The US International Trade Commission has instituted a probe into CSL Behring, a biopharmaceutical company. 10 August 2017
Americas
Big pharma is confronted with little competition in Mexico, with 22 drugs facing no generic rivals in the country. 10 August 2017
Americas
The US Food and Drug Administration finalised 46 product-specific bioequivalence guidances in August. 9 August 2017
Americas
Biopharmaceutical company Dermira has acquired the licensing rights to lebrikizumab, a treatment for atopic dermatitis, from Roche. 9 August 2017
Americas
Biopharma company Coherus BioSciences has filed a petition for inter partes review of a patent controlled by Amgen. 8 August 2017
Americas
Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients. 7 August 2017